MaxCyte and Kamau Therapeutics Partner to Accelerate Gene Correction with Groundbreaking Stem Cell Therapies for Genetic Diseases
In a groundbreaking move for stem cell therapies, MaxCyte, Inc. has entered into a strategic platform license agreement with Kamau Therapeutics, a clinical-stage company focused on gene correction. The collaboration will leverage MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to expedite the development of innovative therapies targeting genetic diseases. Kamau’s platform, built on homology-directed repair […]
Riding Towards Hope: NMDP Cycle’s Nationwide Mission
A Journey of Compassion and Challenge On March 30, the NMDP Cycle, previously known as the Be The Match® Tour de TC, embarks on a transformative six-ride tour across the United States. This inspiring event is not just a test of endurance and strength but a beacon of hope for those awaiting life-saving blood stem […]
Stem Cell Strategies for Sickle Cell Cure
Welcome to our article on stem cell approaches for sickle cell anemia treatment. Sickle cell disease (SCD) affects thousands of Americans and millions worldwide, primarily those of African descent. Unfortunately, it remains an incurable condition for most individuals. However, there is hope in the form of stem cell strategies that offer the potential for a […]
RoslinCT and the Revolutionary CRISPR-Based Gene Therapy CASGEVY™
RoslinCT, a renowned cell and gene therapy Contract Development and Manufacturing Organisation (CDMO), has achieved a groundbreaking milestone in the field of medical science. Building on its legacy since the cloning of Dolly the Sheep at the Roslin Institute in 1997, RoslinCT has now been entrusted with the manufacturing of the first-ever U.S. Food and […]
Stem Cell Transplant as a Curative Treatment for Sickle Cell Disease
Hosted by Expecting Health in collaboration with Be The Match, this webinar delved into the current practices and considerations surrounding bone marrow transplant as a potential curative treatment for Sickle Cell disease. The session aimed to shed light on the intricacies of the transplant process and to amplify awareness within the newborn screening community. Speakers: […]
Stem Cells Unlock Cure: Sickle Cell Gene Therapy Revolution
The podcast episode titled “Stem Cell Gene Therapy Clinical Trial to eliminate Sickle Cell Disease” from Regen Med Global features Dr. Donald Kohn, a UCLA Professor for the Departments of Microbiology, Immunology & Molecular Genetics; Pediatrics; Molecular & Medical Pharmacology. Dr. Kohn begins by sharing his background, including his education and his interest in research […]